Best VCs for Medical Technology

Principal

APEX Ventures

Golnaz Borghei invests through APEX Ventures's published strategy: Back European deep-tech companies from Seed to Series A across AI, autonomous systems, robotics, energy transition, next-generation c

ESG & Operations Associate

APEX Ventures

Olivia Doppler supports APEX Ventures, whose published strategy is: Back European deep-tech companies from Seed to Series A across AI, autonomous systems, robotics, energy transition, next-generation

Investment Committee Member, Amadeus APEX Technology Fund

APEX Ventures

Anne Glover invests through APEX Ventures's published strategy: Back European deep-tech companies from Seed to Series A across AI, autonomous systems, robotics, energy transition, next-generation comp

Investment Committee Member, Amadeus APEX Technology Fund

APEX Ventures

Hermann Hauser invests through APEX Ventures's published strategy: Back European deep-tech companies from Seed to Series A across AI, autonomous systems, robotics, energy transition, next-generation c

Investment Associate

APEX Ventures

Tim Hos invests through APEX Ventures's published strategy: Back European deep-tech companies from Seed to Series A across AI, autonomous systems, robotics, energy transition, next-generation computin

Investment Partner

APEX Ventures

Ion Hauer invests through APEX Ventures's published strategy: Back European deep-tech companies from Seed to Series A across AI, autonomous systems, robotics, energy transition, next-generation comput

Managing Director

Ohio Innovation Fund

Bill Baumel invests or supports investments through Ohio Innovation Fund's published strategy: Back transformative, disruptive and breakthrough founders in AI, medtech, AR/VR, cybersecurity, SaaS and

Venture Partner

Ohio Innovation Fund

Michael Hughes invests or supports investments through Ohio Innovation Fund's published strategy: Back transformative, disruptive and breakthrough founders in AI, medtech, AR/VR, cybersecurity, SaaS a

Venture Partner

Ohio Innovation Fund

Mike Triplett invests or supports investments through Ohio Innovation Fund's published strategy: Back transformative, disruptive and breakthrough founders in AI, medtech, AR/VR, cybersecurity, SaaS an

Venture Advisor

Ohio Innovation Fund

Jeff Schumann is listed in a Venture Advisor capacity at Ohio Innovation Fund. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction

Principal

Ohio Innovation Fund

Faith Voinovich invests or supports investments through Ohio Innovation Fund's published strategy: Back transformative, disruptive and breakthrough founders in AI, medtech, AR/VR, cybersecurity, SaaS

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Chief Financial Officer

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Special Advisor

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Head of Investor Relations

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Associate

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Operations Analyst

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Partner and Fund Manager

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Program Manager

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Operating Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Managing Partner

Cottonwood Technology Fund

Dave Blivin contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

General Partner

Cottonwood Technology Fund

Alain le Loux contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

Partner

Cottonwood Technology Fund

Lee Rand contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

Principal

Cottonwood Technology Fund

Ytsen van der Meer contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europ

Corporate & Investor Relations

Cottonwood Technology Fund

Sabine Jansen contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

Technology Analyst

Cottonwood Technology Fund

Shinjan Dasgupta contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

Investment Analyst

Cottonwood Technology Fund

Daan Boekhoudt contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

SLP & Venture Partner

Cottonwood Technology Fund

Charles Call contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

SLP & Venture Partner

Cottonwood Technology Fund

Alan Abbott contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.

General Partner

Nina Capital

Marc Subirats invests or supports investment work through Nina Capital. Nina Capital's published strategy is to help thoughtful health-technology teams bridge from founding to Series A using a need-dr

Founder and Managing Partner

Nina Capital

Marta G. Zanchi invests or supports investment work through Nina Capital. Nina Capital's published strategy is to help thoughtful health-technology teams bridge from founding to Series A using a need-

Head of Finance

Nina Capital

Jordi Pedrol is listed in a Head of Finance capacity at Nina Capital. No person-specific investment authority is inferred; the firm's mandate is retained only as shared context.

Partner

Nina Capital

Sebastian Anastassiou invests or supports investment work through Nina Capital. Nina Capital's published strategy is to help thoughtful health-technology teams bridge from founding to Series A using a

Partner

Nina Capital

Yahel Halamish invests or supports investment work through Nina Capital. Nina Capital's published strategy is to help thoughtful health-technology teams bridge from founding to Series A using a need-d

Investment Manager

Nina Capital

Kyle Sherrill invests or supports investment work through Nina Capital. Nina Capital's published strategy is to help thoughtful health-technology teams bridge from founding to Series A using a need-dr

Senior Analyst

Nina Capital

Fiorela Kapllanaj invests or supports investment work through Nina Capital. Nina Capital's published strategy is to help thoughtful health-technology teams bridge from founding to Series A using a nee

Chief Partnership Officer

Nina Capital

Bob Schulz is listed in a Chief Partnership Officer capacity at Nina Capital. No person-specific investment authority is inferred; the firm's mandate is retained only as shared context.

Community Manager

Nina Capital

Aline Noizet is listed in a Community Manager capacity at Nina Capital. No person-specific investment authority is inferred; the firm's mandate is retained only as shared context.

Visiting Analyst

Nina Capital

Guillem Torruella invests or supports investment work through Nina Capital. Nina Capital's published strategy is to help thoughtful health-technology teams bridge from founding to Series A using a nee

Visiting Analyst

Nina Capital

Olivia Escudero invests or supports investment work through Nina Capital. Nina Capital's published strategy is to help thoughtful health-technology teams bridge from founding to Series A using a need-

Founder & General Partner

APEX Ventures

Andreas Riegler invests through APEX Ventures's published strategy: Back European deep-tech companies from Seed to Series A across AI, autonomous systems, robotics, energy transition, next-generation

General Partner

APEX Ventures

Wolfgang Neubert invests through APEX Ventures's published strategy: Back European deep-tech companies from Seed to Series A across AI, autonomous systems, robotics, energy transition, next-generation

Founding Partner & General Partner

APEX Ventures

Stefan Haubner invests through APEX Ventures's published strategy: Back European deep-tech companies from Seed to Series A across AI, autonomous systems, robotics, energy transition, next-generation c

Chief Financial Officer

APEX Ventures

Marcell Farkas supports APEX Ventures, whose published strategy is: Back European deep-tech companies from Seed to Series A across AI, autonomous systems, robotics, energy transition, next-generation

Advisor

Rock Health Capital

Hylton Kalvaria is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and use

Advisor

Rock Health Capital

Keith W. Anderson is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and u

Advisor

Rock Health Capital

Monique Smith is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses

Founder and General Partner

Rock Health Capital

Bill Evans invests or supports investments through Rock Health Capital's published strategy: Invest in remarkable entrepreneurs working at the intersection of healthcare and technology to make healthc

Principal

Rock Health Capital

Sean Day invests or supports investments through Rock Health Capital's published strategy: Invest in remarkable entrepreneurs working at the intersection of healthcare and technology to make healthcar